To include your compound in the COVID-19 Resource Center, submit it here.

EMA, FDA accept applications for Vertex's tezacaftor/ivacaftor for CF

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) said EMA and FDA accepted for review regulatory applications for Tezacaftor (VX-661)/ivacaftor (Tez/Iva)

Read the full 177 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE